Cooler Heads Presented at WAA's 11-Jul Life Sciences Pitch Event.
A post pitch call is on Monday, 22-Jul-2024 at 10am - 10:45am PT // 1pm - 1:45pm ET.
Please submit due diligence questions for Headache Sciences: Cooler Heads_DD_Pitch Follow-up Questions_11-Jul-2024
Joining information will be sent upon registration.
Cooler Heads uses technology to help cancer patients and survivors address the common complex side effects of treatment.
PROBLEM: Cooler Heads is building the evidence based products, content and services cancer patients and survivors need to manage the complex side effects of treatment. Our first product, Amma, is the only solution that makes it possible for infusion centers to profitably offer scalp cooling therapy so chemotherapy patients can keep their hair.
SOLUTION: Scalp cooling has to start before chemotherapy begins and continues for at least 2 hours following the infusion. Legacy solutions double the amount of time a patient is in the infusion chair making it too expensive for infusion centers. Amma allows patients to continue cooling out of the chair and a pricing structure that makes it profitable.
- Cooler Heads Pitch Deck
- Cooler Heads Deal Terms (will be added soon. WAA Members can check Dealum for update in the "Documents" tab for Cooler Heads)
- Cooler Heads allocation for WAA: Open to negotiation
- Cooler Heads on Dealum
- 1-cooler-heads on Slack